» Articles » PMID: 15699460

14,15-epoxyeicosatrienoic Acid Represents a Transferable Endothelium-dependent Relaxing Factor in Bovine Coronary Arteries

Overview
Journal Hypertension
Date 2005 Feb 9
PMID 15699460
Citations 30
Authors
Affiliations
Soon will be listed here.
Abstract

Bradykinin causes arterial relaxation and hyperpolarization, which is mediated by a transferable endothelium-derived hyperpolarizing factor (EDHF). In coronary arteries, epoxyeicosatrienoic acids (EETs) are involved in the EDHF response. However, the role of EETs as transferable mediators of EDHF-dependent relaxation remains poorly defined. Two small bovine coronary arteries were cannulated and perfused in tandem in the presence of the nitric oxide synthase inhibitor, nitro-L-arginine (30 micromol/L), and the cyclooxygenase inhibitor, indomethacin (10 micromol/L). Luminal perfusate from donor arteries with intact endothelium perfused endothelium-denuded detector arteries. Detector arteries were constricted with U46619 and diameters were monitored. Bradykinin (10 nmol/L) added to detector arteries did not induce dilation (5+/-2%), whereas bradykinin addition to donor arteries dilated detector arteries by 26.5+/-7% (P<0.05). These dilations were blocked by donor artery endothelium removal and detector artery treatment with the EET-selective antagonist, 14,15-epoxyeicosa-5(Z)-monoenoic acid (14,15-EEZE; 10 micromol/L, -5+/-6%) but not 14,15-EEZE treatment of donor arteries (20+/-5%). 14,15-EET (0.1 to 10 micromol/L) added to detector arteries induced maximal dilations of 82+/-5% that were inhibited 50% by detector artery treatment with 14,15-EEZE (32+/-12%) but not donor artery treatment with 14,15-EEZE. Liquid chromatography-electrospray ionization mass spectrometry analysis verified the presence of 14,15-EET in the perfusate from an endothelium-intact but not denuded artery. These results show that bradykinin stimulates donor artery 14,15-EET release that dilates detector arteries. 14,15-EEZE blocked the donor artery, endothelium-dependent, bradykinin-induced relaxations, and attenuated relaxations to 14,15-EET. These results suggest that EETs are transferable EDHFs in coronary arteries.

Citing Articles

Cytochrome P450-derived Epoxyeicosatrienoic Acid, the Regulation of Cardiovascular-related Diseases, and the Implication for Pulmonary Hypertension.

Lan R, Zhang M, Liu K, Meng F, Xu X, Wang C Cardiovasc Drugs Ther. 2024; .

PMID: 39652233 DOI: 10.1007/s10557-024-07655-0.


14,15-Dihydroxyeicosatrienoic acid, a soluble epoxide hydrolase metabolite in blood, is a predictor of anthracycline-induced cardiotoxicity - a hypothesis generating study.

Dos Santos J, Joiakim A, Putt D, Scherrer-Crosbie M, Kim H Cardiooncology. 2023; 9(1):47.

PMID: 38102716 PMC: 10722875. DOI: 10.1186/s40959-023-00198-7.


Pathophysiology and Outcomes of Endothelium Function in Coronary Microvascular Diseases: A Systematic Review of Randomized Controlled Trials and Multicenter Study.

Avtaar Singh S, Nappi F Biomedicines. 2022; 10(12).

PMID: 36551766 PMC: 9775403. DOI: 10.3390/biomedicines10123010.


Redox Regulation of Soluble Epoxide Hydrolase-Implications for Cardiovascular Health and Disease.

Charles R, Eaton P Cells. 2022; 11(12).

PMID: 35741062 PMC: 9221603. DOI: 10.3390/cells11121932.


Orally Active Epoxyeicosatrienoic Acid Analogs.

Campbell W, Imig J, Schmitz J, Falck J J Cardiovasc Pharmacol. 2017; 70(4):211-224.

PMID: 28937442 PMC: 5673125. DOI: 10.1097/FJC.0000000000000523.